Josep Prous Jr.

Co-Founder, CSO & Board Member at Connecta Therapeutics

Josep Prous Jr. is Vice President of R&D at Prous Institute for Biomedical Research and Strategic Advisor to life sciences organizations, where he is responsible for the design and implementation of in silico drug discovery and safety technologies. He was previously Vice President and Chief Scientific Officer of the Healthcare and Science business of Thomson Reuters, following the acquisition of his former company Prous Science by Thomson Scientific. He has longstanding experience in establishing fruitful collaborations with biomedical research organizations. Josep holds a BS in Chemistry and an MBA from the ESADE Business School. He completed his Ph.D. doctoral thesis, spearheading a medicinal chemistry project for the discovery of new drugs for Alzheimer's disease.


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Connecta Therapeutics

Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.


Headquarters

Barcelona, Spain

Employees

1-10

Links